PT886, an anti-claudin18.2/anti-CD47 bispecific antibody constructed with the PACbody(TM) and SPECpair(TM) technology platforms, exhibits robust anti-tumor activity in a pancreatic cancer xenograft model
CANCER RESEARCH（2022）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined